On this page
Anascorp
Centruroides (Scorpion) Immune F(ab')2 (Equine) Injection
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Anascorp
Proper name
Centruroides (Scorpion) Immune F(ab')2 (Equine) Injection
Licence type
351(a)
BLA number
125335
Applicant
Rare Disease Therapeutics, Inc. (RDT)
Center
CBER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| >/=150 LD50 NEUTRALIZING UNITS | For Injection | Intravenous | Single-Dose Vial | Rx | August 3, 2011 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | August 4, 2018 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |